Hey Team,
Just wanting something cleared up which I am slightly confused about - I noticed on the 13th December that we received FDA approval to "initiate a new phase 2 clinical trial of its immunotherapy candidate, HER-Vaxx". Although looking at the clinical pipeline section of the Imugene website, it clearly states that we are almost 3 quarters through our phase 2 trial, photo displayed below:
So my question is, have we already started our phase 2 clinical trials without FDA approval or is the above image incorrect?
Ann: Imugene HER-Vaxx Immunotherapy Patent Allowed in China, page-108
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $505.0M | |||
| Open | High | Low | Value | Volume |
| 7.0¢ | 7.1¢ | 6.8¢ | $1.427M | 20.55M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 57517 | 6.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.0¢ | 667419 | 9 |
View Market Depth
| Last trade - 16.10pm 21/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.9¢ |
Change
0.000 ( 0.29 %) |
||||
| Open | High | Low | Volume | ||
| 6.9¢ | 7.1¢ | 6.8¢ | 7149293 | ||
| Last updated 15.59pm 21/05/2024 ? | |||||
| IMU (ASX) Chart |